share_log

海普瑞(002399.SZ):依诺肝素钠注射液获新西兰药品注册批件

Hyperion (002399.SZ): Enoxaparin sodium injection obtained New Zealand drug registration approval

Zhitong Finance ·  Mar 28 11:45

Haipuri (002399.SZ) announced that the company's wholly-owned subsidiary, Shenzhen Tiandao Pharmaceutical Co., Ltd. (abbreviated as “Tiandao...

Zhitong Finance App News, Hyperui (002399.SZ) announced that Shenzhen Tiandao Pharmaceutical Co., Ltd. (“Tiandao Pharmaceutical”), a wholly-owned subsidiary of the company, recently received an approval notice for enoxaparin sodium injections issued by the New Zealand Drug and Medical Device Safety Authority (MEDSAFE).

This approval means that Hypree's enoxaparin sodium preparations can be sold in the New Zealand market, which will further increase the global market share of the company's enoxaparin sodium preparations.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment